Noted Cedars-Sinai Executive and L.A. Attorney
Named Chair of Board of Trustees for Charles R. Drew University of Medicine and Science

Arthur J. Ochoa, JD, assumes leadership of health professions institution’s governance board

FOR IMMEDIATE RELEASE

2018-9-11 MOU West Angeles Church COGICLOS ANGELES, Calif. (March 5, 2019) – Arthur J. Ochoa, JD, Senior Vice President of Advancement and Chief Advancement Officer for Cedars-Sinai, has been named Chair of the Board of Trustees for Charles R. Drew University of Medicine and Science (CDU).
He is CDU’s first Latino Chair of the Board of Trustees, and has been on CDU’s Board of Trustees since 2012.  Previously, he served as Vice Chair and headed the Development Committee.

Mr. Ochoa succeeds Dignity Health Senior Executive Vice President/Chief Operating Officer Marvin O’Quinn, MPH, who had served as Board of Trustees Chair since 2013.

Arthur J. Ochoa has been with Cedars-Sinai since 2001, and the organization has raised more than $1 billion in philanthropic support since his appointment as Chief Development Officer in 2004. In addition to leading Cedars-Sinai’s development, Mr. Ochoa also leads its community engagement and marketing communication teams. Prior to joining Cedars-Sinai, he practiced corporate and tax law at the Los Angeles offices of O'Melveny & Myers LLP and Irell & Manella LLP. He is a past chairman of the Los Angeles County Bar Association Tax Exempt Organization Committee.

In addition to his leadership role at CDU, Mr. Ochoa is vice president of the board of Marlborough School, a board member of the Pacific Council on International Policy, a member of the Yale Law School Association’s Executive Board and an honorary trustee of the Mexican American Bar Foundation.  He has been board chair of Planned Parenthood Los Angeles and is a past board president of the Center for Early Education. His community awards include recognition from the National Hispanic Health Foundation, the Mexican American Bar Foundation and Boy Scouts of America, among others.

Mr. Ochoa received his undergraduate degree from the University of Southern California (cum laude and Phi Beta Kappa) and his law degree from Yale Law School.

“CDU is fortunate to have a seasoned healthcare and development executive in Art Ochoa at the helm of our Board of Trustees,” said CDU President and CEO Dr. David M. Carlisle.  “Art has contributed immeasurably to our stability and growth during his time on the Board, and we look forward to his leadership as Chair.  We also express our deep gratitude to Marvin O’Quinn for his steady Board leadership over the last five years, and we are pleased that he will continue to serve on the Board.”

“It is an honor to be selected to lead the Board of Trustees of Charles R. Drew University,” said Mr. Ochoa.  “I share the school’s passion for their mission and objectives:  to work for social justice and health equity, to eliminate health disparities and to educate and train the healthcare workforce of the future.  I look forward to working with Dr. Carlisle, his exceptional executive team and my fellow  trustees to help grow the University, its enrollment and its philanthropic support.”

###

 ABOUT CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
CDU is a private, non-profit student centered minority-serving medical and health sciences University that is committed to cultivating diverse health professional leaders who are dedicated to social justice and health equity for underserved populations through outstanding education, research, clinical service, and community engagement.

Located in the Watts-Willowbrook area of South Los Angeles, CDU has graduated, since its inception, more than 575 physicians, 1,200 physician assistants and over a thousand other health professionals, as well as training over 2,700 physician specialists through its sponsored residency programs. Its School of Nursing has graduated over 1000 nursing professionals, including over 600 family nurse practitioners.  CDU is a leader in health disparities research with a focus on education, training, treatment and care in cancer, diabetes, cardiometabolic and HIV/AIDS.